Walmart Card Table, Folding Chairs Recall Issued After Finger Amputations
Roughly 73,400 folding card table and chair sets sold exclusively at Walmart have been recalled after the manufacturer received multiple reports of the chairs collapsing and causing injuries for consumers, including finger and fingertip amputations.
The Mainstays five-piece card table recall was announced by the U.S. Consumer Product Safety Commission (CPSC) on January 2, following at least 10 reports of injuries from collapsing chairs including one finger amputation, three fingertip amputations, sprained or fractured fingers and one report of back stiffness.
The recall includes black padded foldable Mainstays card tables sold with four black vinyl upholstered chair with foam padding. The tables measure roughly 34″L x 34″W x 28″H and the chairs measure roughly 15.8″L x 15.8″W x 17.5″H. The metal chairs have the words “Made by:Dongguan Shin Din Metal & Plastic Products Co,” printed on a white label located on the bottom of the seat.
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
The affected table and chairs sets were manufactured in China and Taiwan under Heshan Camis Industrial Co. Ltd., of Guangdong where they were imported and sold exclusively at Walmart stores nationwide and online at www.walmart.com from May 2013 through November 2013 for about $50.
The CPSC recommends that customers with affected card table sets stop using the products immediately and contact Walmart at (800) 925-6278 or visit them online at www.walmart.com and navigate to the “Product Recalls” link for further information.
"*" indicates required fields
More Top Stories
A ProPublica report reveals that Philips officials hid thousands of reports of problems with sound abatement foam used in millions of CPAP machines, failing to recall the devices for more than a decade after receiving the first complaints.
A Suboxone lawsuit claims the opioid addiction treatment's dental side effects can lead to severe tooth damage and decay.
The FDA is requiring new label warnings to alert patients and doctors to the risk of Ozempic intestinal blockage side effects.